Skip to main content
Clinical Trials/CTRI/2022/07/043709
CTRI/2022/07/043709
Not yet recruiting
未知

nderstanding the effect of diabetes mellitus on immunometabolic response to Burkholderia pseudomallei in Indian patients

ICMR0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: A499- Bacterial infection, unspecified
Sponsor
ICMR
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
ICMR

Eligibility Criteria

Inclusion Criteria

  • Melioidosis:
  • 1\)Patients diagnosed with melioidosis only
  • 2\)No past history of receiving any melioidosis treatment
  • 3\)Above 18yrs of age
  • 4\)Patients with or without COVID\-19 co\-Infection
  • Diabetes mellitus only:
  • 1\) Patients diagnosed with type\-II diabetes mellitus
  • 2\) Patients on diabetes mellitus treatment
  • Healthy controls:
  • 1\) Individuals with no history of diabetes mellitus

Exclusion Criteria

  • Melioidosis:
  • 1\) Patients with previous history of melioidosis
  • 2\) Patients with other co\-infection
  • 3\) Relapse cases of melioidosis
  • 4\) Below 18yrs of age
  • Diabetes mellitus only:
  • 1\) Patients with acute infection
  • Healthy controls:
  • 1\) Individuals with no evidence of any active or chronic disease

Outcomes

Primary Outcomes

Not specified

Similar Trials